Malaria and Dengue diseases

Malaria and Dengue diseases

Malaria fever
Malaria is a mosquito-borne infectious disease that affects humans and other animals.[2] Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches.[1] In severe cases it can cause yellow skin, seizures, coma, or death.[1] Symptoms usually begin ten to fifteen days after being bitten by an infected mosquito.[2] If not properly treated, people may have recurrences of the disease months later.[2] In those who have recently survived an infection, reinfection usually causes milder symptoms.[1] This partial resistance disappears over months to years if the person has no continuing exposure to malaria.[1]

Malaria
Malaria Parasite Connecting to Human Red Blood Cell (34034143483).jpg
Malaria parasite connecting to a red blood cell
Pronunciation
/məˈlɛəriə/
Specialty
Infectious disease
Symptoms
Fever, vomiting, headache[1]
Complications
Yellow skin, seizures, coma[1]
Usual onset
10–15 days post exposure[2]
Causes
Plasmodium spread by mosquitos[1]
Diagnostic method
Examination of the blood, antigen detection tests[1]
Prevention
Mosquito nets, insect repellent, mosquito control, medications[1]
Medication
Antimalarial medication[2]
Frequency
216 million (2016)[3]
Deaths
445,000 to 731,000[3][4]
It is caused by single-celled microorganisms of the Plasmodium group.[2] The disease is most commonly spread by an infected female Anopheles mosquito.[2] The mosquito bite introduces the parasites from the mosquito’s saliva into a person’s blood.[2] The parasites travel to the liver where they mature and reproduce.[1] Five species of Plasmodium can infect and be spread by humans.[1] Most deaths are caused by P. falciparum because P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.[1][2] The species P. knowlesi rarely causes disease in humans.[2] Malaria is typically diagnosed by the microscopic examination of blood using blood films, or with antigen-based rapid diagnostic tests.[1] Methods that use the polymerase chain reaction to detect the parasite’s DNA have been developed, but are not widely used in areas where malaria is common due to their cost and complexity.[5]

The risk of disease can be reduced by preventing mosquito bites through the use of mosquito nets and insect repellents, or with mosquito control measures such as spraying insecticides and draining standing water.[1] Several medications are available to prevent malaria in travellers to areas where the disease is common.[2] Occasional doses of the combination medication sulfadoxine/pyrimethamine are recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria.[2] Despite a need, no effective vaccine exists, although efforts to develop one are ongoing.[2] The recommended treatment for malaria is a combination of antimalarial medications that includes an artemisinin.[1][2] The second medication may be either mefloquine, lumefantrine, or sulfadoxine/pyrimethamine.[6] Quinine along with doxycycline may be used if an artemisinin is not available.[6] It is recommended that in areas where the disease is common, malaria is confirmed if possible before treatment is started due to concerns of increasing drug resistance.[2] Resistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia.[2]

The disease is widespread in the tropical and subtropical regions that exist in a broad band around the equator.[1] This includes much of Sub-Saharan Africa, Asia, and Latin America.[2] In 2016, there were 216 million cases of malaria worldwide resulting in an estimated 445,000 to 731,000 deaths.[3][4] Approximately 90% of both cases and deaths occurred in Africa.[7] Rates of disease have decreased from 2000 to 2015 by 37%,[7] but increased from 2014, during which there were 198 million cases.[8] Malaria is commonly associated with poverty and has a major negative effect on economic development.[9][10] In Africa, it is estimated to result in losses of US$12 billion a year due to increased healthcare costs, lost ability to work, and negative effects on tourism.[11]

Dengue fever

Dengue fever
Other names
Dengue, breakbone fever[1][2]
Photograph of a person’s back with the skin exhibiting the characteristic rash of dengue fever
The typical rash seen in dengue fever
Pronunciation
/ˈdɛŋɡeɪ, -ɡi/
Specialty
Infectious disease
Symptoms
Fever, headache, muscle and joint pain, rash[1][2]
Complications
Bleeding, low levels of blood platelets, dangerously low blood pressure[2]
Usual onset
3–14 days after exposure[2]
Duration
2–7 days[1]
Causes
Dengue virus by Aedes mosquitos[1]
Diagnostic method
Detecting antibodies to the virus or its RNA[2]
Differential diagnosis
Malaria, yellow fever, viral hepatitis, leptospirosis[3]
Prevention
Dengue fever vaccine, decreasing mosquito exposure[1][4]
Treatment